Johnson & Johnson (JNJ) PT Raised to $140 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
Johnson & Johnson (JNJ) PT Raised to $147 at Raymond James
April 17, 2019 7:42 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $147.00 (from $145.00) while maintaining a Outperform rating.
growth was still much better than expected, which gives us more confidence in our estimates... MoreJohnson & Johnson (JNJ) PT Raised to $157 at BMO Capital
April 17, 2019 6:56 AM EDTBMO Capital analyst Joanne Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $157.00 (from $154.00) while maintaining a Outperform rating.
Staying On Course in Its Transition Year
tightening EPS to $8.53-$8.63 from $8.50-$8.65
... MoreJohnson & Johnson (JNJ) PT Raised to $145 at Morgan Stanley
April 17, 2019 6:47 AM EDTMorgan Stanley raised its price target on Johnson & Johnson (NYSE: JNJ) to $145.00 (from $134.00) while maintaining a Equalweight rating.
... MoreJohnson & Johnson (JNJ) PT Raised to $150 at RBC Capital
April 17, 2019 6:37 AM EDTRBC Capital analyst Brandon Henry raised the price target on Johnson & Johnson (NYSE: JNJ) to $150.00 (from $144.00) while maintaining a Outperform rating.
Strong start to 2019; revised guidance appears conservative... MoreJohnson & Johnson (JNJ) Tops Q1 EPS by 6c
April 16, 2019 6:41 AM EDT(Updated - April 16, 2019 6:43 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.10, $0.06 better than the analyst estimate of $2.04. Revenue for the quarter came in at $20.02 billion versus the consensus estimate of $19.61 billion.
GUIDANCE:
Johnson & Johnson sees FY2019 EPS of... More
Johnson & Johnson (JNJ) April option implied volatility elevated at 36 into EPS and outlook
April 15, 2019 3:19 PM EDTJohnson & Johnson (NYSE: JNJ) April call option implied volatility is at 36, May is at 18; compared to its 52-week range of 12 to 34 into the expected release of EPS before the bell on April 16.
... More